Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $1,049 | 2 | 48.9% |
| Grant | $700.00 | 1 | 32.7% |
| Food and Beverage | $394.79 | 11 | 18.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allerderm Laboratories | $989.25 | 1 | $0 (2020) |
| Mylan Specialty L.P. | $700.00 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $150.06 | 2 | $0 (2020) |
| Octapharma USA, Inc. | $87.99 | 3 | $0 (2020) |
| Jazz Pharmaceuticals Inc. | $86.60 | 2 | $0 (2017) |
| PFIZER INC. | $40.89 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $29.75 | 1 | $0 (2022) |
| BioCryst US Sales Co., LLC | $25.50 | 1 | $0 (2022) |
| kaleo, Inc. | $17.18 | 1 | $0 (2022) |
| Shire North American Group Inc | $16.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $72.43 | 3 | Regeneron Healthcare Solutions, Inc. ($29.75) |
| 2020 | $1,193 | 5 | Allerderm Laboratories ($989.25) |
| 2018 | $791.17 | 4 | Mylan Specialty L.P. ($700.00) |
| 2017 | $86.60 | 2 | Jazz Pharmaceuticals Inc. ($86.60) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2022 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Immunology | ||||||
| 03/23/2022 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Allergy | ||||||
| 02/10/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2020 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $46.06 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2020 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2020 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: Respiratory | ||||||
| 01/21/2020 | Allerderm Laboratories | — | Education | Cash or cash equivalent | $989.25 | General |
| 11/18/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.96 | General |
| 11/17/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $40.89 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2018 | Mylan Specialty L.P. | — | Grant | Cash or cash equivalent | $700.00 | General |
| 10/15/2018 | Shire North American Group Inc | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: GENETIC DISEASE | ||||||
| 11/09/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Education | In-kind items and services | $59.50 | General |
| Category: Neurology | ||||||
| 10/12/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 78 | 764 | $41,244 | $8,468 |
| 2021 | 5 | 146 | 779 | $67,534 | $15,131 |
| 2020 | 1 | 12 | 12 | $3,955 | $733.08 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 40 | $9,275 | $2,933 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $13,005 | $2,596 | 20.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 13 | 683 | $16,604 | $2,110 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $2,360 | $829.80 | 35.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $24,710 | $5,258 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 58 | $12,945 | $4,582 | 35.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $13,015 | $2,411 | 18.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 15 | 623 | $14,329 | $1,880 | 13.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 17 | $2,535 | $1,000 | 39.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $3,955 | $733.08 | 18.5% |
About Dr. Xuesong Chen, M.D
Dr. Xuesong Chen, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679835284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xuesong Chen, M.D has received a total of $2,144 in payments from pharmaceutical and medical device companies, with $72.43 received in 2022. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Education" ($1,049).
As a Medicare-enrolled provider, Chen has provided services to 236 Medicare beneficiaries, totaling 1,555 services with total Medicare billing of $24,333. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Houston, TX
- Active Since 06/10/2012
- Last Updated 09/22/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679835284
Products in Payments
- FASENRA (Drug) $116.10
- CUTAQUIG (Biological) $87.99
- Xyrem (Drug) $86.60
- EUCRISA (Drug) $40.89
- DUPIXENT (Biological) $29.75
- ORLADEYO (Drug) $25.50
- AUVI-Q (Drug) $17.18
- TAKHZYRO (Biological) $16.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947